Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selenium Supplementation for Influenza Vaccination Response
NCT04188483Completed
- Sponsor
- Huazhong University of Science and Technology
- Start
- Oct 2019
- Primary completion
- Dec 2019
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Huazhong University of Science and Technology. Primary endpoint: The production of antigen-specific antibodies after vaccination at 60 days. Started Oct 2019; status: completed.
Beyond the preview
Go deeper on NCT04188483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04188483.